DOI: 10.12890/2020_001981
The Relationship of Cholangiocarcinoma with Human Immunodeficiency Virus Cholangiopathy and Cytomegalovirus Infection
Authors
ardayavuz55@hotmail.com
Keywords
Hepatosteatosis, late-onset lipid storage myopathy, lipid storage diseaseAbstract
Human immunodeficiency virus (HIV) is a worldwide disease with an increasing number of cases globally. Initially, HIV cholangiopathy was often observed among such patients but has become rare after three decades because of the availability of new treatment options and potent antiretroviral drugs. Consequently, its occurrence now suggests drug resistance or disease progression. The relationship between cholangiocarcinoma and HIV remains unclear. We report the case of a patient with high-grade dysplasia of the ductus choledochus and uncontrolled disease which was treated with potent antiviral agents and bile duct dilatation.
References
- Cello JP, Chan MF. Long-term follow-up of endoscopic retrograde cholangiopancreatography sphincterotomy for patients with acquired immune deficiency syndrome papillary stenosis. Am J Med 1995;99(6):600–603.
- Lazardis KN, Gores GJ. Cholangiocarcinoma. Gastroenterology 2005;128(6):1655–1667.
- Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case control study. Gastroenterology 2005;128(3):620–626.
- Wilcox CM, Mönkemüller KE. Hepatobiliary diseases in patients with AIDS: focus on AIDS cholangiopathy and gallbladder disease. Dig Dis 1998;16(4):205–213.
- Imai K, Misawa K, Matsumura T, Fujikura Y, Mikita K, Tokoro M, et al. Progressive HIV-associated cholangiopathy in an HIV patient treated with combination antiretroviral therapy. Intern Med 2016;55(19):2881–2884.